{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:59:14Z","timestamp":1789685954829,"version":"4.0.1"},"reference-count":36,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Candidemia is one of the healthcare-associated infections that has high mortality. The risk factors that predispose a patient to develop this infection are mostly found in patients of greater severity and COVID-19 contributes to the risk of death. The aim of this study is to evaluate epidemiological characteristics and risk factors for mortality in patients with candidemia before and during the COVID-19 pandemic era. This is a retrospective study conducted at Instituto Central from 2016 to 2020 of patients with candidemia that were evaluated for demographic data, medical history, risk factors, microbiological data, therapeutic measures, complementary exams, device management, and outcome defined by 30-day mortality. A total of 170 episodes were included (58.2% males; mean age of 56 years). The overall incidence density of candidemia per 1000 admissions and per 1000 patient-days was 1.17 and 0.17, respectively, with an increase of 38% in the year 2020. The use of a central venous catheter was the most prevalent (93.5%) condition, followed by the previous use of antibiotics (91.1%). Corticosteroid use ranked seventh (56.4%). C. albicans was responsible for 71 (41.7%) of the isolates, followed by C. tropicalis and C. glabrata, with 34 (20%) isolates each. Echinocandin was prescribed in 60.1% of cases and fluconazole in 37%. Echocardiography resulted in six (5.08%) cases of endocarditis and fundoscopy resulting in two (2.4%) endophthalmitis. The 30-day mortality was 93\/170 (54.7%). The risk factors associated with mortality were age (OR 1.03, CI 95% 1.01\u20131.06), heart disease (OR 7.51, CI 95% 1.48\u201337.9), hemodialysis (OR 3.68, CI 95% 1.28\u201310.57), and use of corticosteroids (OR 2.83, CI 95% 1.01\u20137.92). The COVID-19 pandemic had an impact on the increase incidence of candidemia. The persistently high mortality highlights the need for better management strategies, control of risk factors, and guarantee of adequate treatment.<\/jats:p>","DOI":"10.3390\/jof10040268","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T03:37:21Z","timestamp":1712115441000},"page":"268","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiological Assessment and Risk Factors for Mortality of Bloodstream Infections by Candida sp. and the Impact of the COVID-19 Pandemic Era"],"prefix":"10.3390","volume":"10","author":[{"given":"Jordana Machado","family":"Araujo","sequence":"first","affiliation":[{"name":"Infection Control Department, Hospital das Cl\u00ednicas, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-026X","authenticated-orcid":false,"given":"Jo\u00e3o N\u00f3brega","family":"de Almeida Junior","sequence":"additional","affiliation":[{"name":"Central Laboratory Division, Hospital das Cl\u00ednicas, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-8265","authenticated-orcid":false,"given":"Marcello Mihailenko Chaves","family":"Magri","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital das Cl\u00ednicas, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital das Cl\u00ednicas, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7282-5453","authenticated-orcid":false,"given":"Tha\u00eds","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Infection Control Department, Hospital das Cl\u00ednicas, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","article-title":"Brazilian guidelines for the management of candidiasis\u2014A joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical","volume":"17","author":"Colombo","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/23744235.2016.1207251","article-title":"International guidelines: The need to standardize the management of candidaemia","volume":"48","author":"Jack","year":"2016","journal-title":"Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ben-Ami, R. (2018). Treatment of Invasive Candidiasis: A Narrative Review. J. Fungi, 4.","DOI":"10.3390\/jof4030097"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kaur, H., and Chakrabarti, A. (2017). Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries. J. Fungi, 3.","DOI":"10.3390\/jof3030041"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijid.2020.06.044","article-title":"COVID-19 epidemic in Brazil: Where are we at?","volume":"97","author":"Lobo","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/13693780802004996","article-title":"Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital","volume":"46","author":"Levin","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1413-8670(10)70091-X","article-title":"Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex","volume":"14","author":"Motta","year":"2010","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102353","DOI":"10.1016\/j.bjid.2022.102353","article-title":"Increased incidence of candidemia in critically ill patients during the Coronavirus Disease 2019 (COVID-19) pandemic","volume":"26","author":"Kolonitsiou","year":"2022","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.33073\/pjm-2022-036","article-title":"Opportunistic Candida Infections in Critical COVID-19 Patients","volume":"71","author":"Sav","year":"2022","journal-title":"Pol. J. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Riche, C.V.W., Cassol, R., and Pasqualotto, A.C. (2020). Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?. J. Fungi, 6.","DOI":"10.3390\/jof6040286"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/myc.13531","article-title":"Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients","volume":"66","author":"Kayaaslan","year":"2023","journal-title":"Mycoses"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_19","first-page":"32","article-title":"Risk factors and lethality associated with Candidemia in severe COVID-19 patients","volume":"8","author":"Sav","year":"2022","journal-title":"Curr. Med. Mycol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e0762","DOI":"10.1097\/CCE.0000000000000762","article-title":"Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19","volume":"4","author":"Dixit","year":"2022","journal-title":"Crit. Care Explor."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ofac605","DOI":"10.1093\/ofid\/ofac605","article-title":"Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic","volume":"9","author":"Zaragoza","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Doi, A.M., Pignatari, A.C., Edmond, M.B., Marra, A.R., Camargo, L.F., Siqueira, R.A., da Mota, V.P., and Colombo, A.L. (2016). Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146909"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4067\/S0716-10182017000500431","article-title":"Epidemiolog\u00eda, especies, resistencia antif\u00fangica y evoluci\u00f3n de las candidemias en un hospital universitario de Buenos Aires, Argentina, durante 16 a\u00f1os [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years]","volume":"34","author":"Tiraboschi","year":"2017","journal-title":"Rev. Chilena Infectol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejim.2016.08.020","article-title":"Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy","volume":"34","author":"Tedeschi","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/13693786.2012.708107","article-title":"Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil","volume":"51","author":"Moretti","year":"2013","journal-title":"Med. Mycol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e20190206","DOI":"10.1590\/0037-8682-0206-2019","article-title":"Risk factors associated with mortality among patients who had candidemia in a university hospital","volume":"53","author":"Alves","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rodrigues, D.K.B., Bonfietti, L.X., Garcia, R.A., Araujo, M.R., Rodrigues, J.S., Gimenes, V.M.F., and Melhem, M.S.C. (2021). Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of S\u00e3o Paulo State, Brazil. Braz. J. Med. Biol. Res., 54.","DOI":"10.1590\/1414-431x2020e10928"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Agnelli, C., Guimar\u00e3es, T., Sukiennik, T., Lima, P.R.P., Salles, M.J., Breda, G.L., Queiroz-Telles, F., Chaves Magri, M.M., Mendes, A.V., and Camargo, L.F.A. (2023). Prognostic Trends and Current Challenges in Candidemia: A Comparative Analysis of Two Multicenter Cohorts within the Past Decade. J. Fungi, 9.","DOI":"10.3390\/jof9040468"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Franconi, I., Rizzato, C., Tavanti, A., Falcone, M., and Lupetti, A. (2023). Paradigm Shift: Candida parapsilosis sensu stricto as the most prevalent Candida species isolated from bloodstream infections with increasing azole-non-susceptibility rates: Trends from 2015\u20132022 survey. J. Fungi, 9.","DOI":"10.3390\/jof9101012"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I.N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M.E., Thompson, L., and Sifuentes-Osornio, J. (2013). Epidemiology of candidemia in Latin America: A laboratory-based survey. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059373"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bjid.2018.07.008","article-title":"Secular trends of candidemia at a Brazilian tertiary care teaching hospital","volume":"22","author":"Braga","year":"2018","journal-title":"Braz. J. Infect Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2021031","DOI":"10.4084\/MJHID.2021.031","article-title":"Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study","volume":"13","author":"Husni","year":"2021","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_35","first-page":"100117","article-title":"Prognostic factors of Candida spp. bloodstream infection in adults: A nine-year retrospective cohort study across tertiary hospitals in Brazil and Spain","volume":"6","author":"Agnelli","year":"2021","journal-title":"Lancet Reg. Health\u2013Am."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12281-023-00456-2","article-title":"The Impact of Corticosteroids on the Outcome of Fungal Disease: A Systematic Review and Meta-analysis","volume":"17","author":"Li","year":"2023","journal-title":"Curr. Fungal. Infect. Rep."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/4\/268\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:22:50Z","timestamp":1760106170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/4\/268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jof10040268"],"URL":"https:\/\/doi.org\/10.3390\/jof10040268","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]}}}